Akero Short Long Term Debt Total from 2010 to 2024

AKRO Stock  USD 19.48  1.02  4.98%   
Akero Therapeutics Short and Long Term Debt Total yearly trend continues to be very stable with very little volatility. Short and Long Term Debt Total is likely to grow to about 27.3 M this year. During the period from 2010 to 2024, Akero Therapeutics Short and Long Term Debt Total quarterly data regression pattern had sample variance of 78.1 T and median of  1,810,000. View All Fundamentals
 
Short and Long Term Debt Total  
First Reported
2010-12-31
Previous Quarter
26 M
Current Value
27.3 M
Quarterly Volatility
8.8 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Akero Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Akero main balance sheet or income statement drivers, such as Discontinued Operations of 0.0, Interest Expense of 3.3 M or Selling General Administrative of 29 K, as well as many exotic indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 1.49. Akero financial statements analysis is a perfect complement when working with Akero Therapeutics Valuation or Volatility modules.
  
This module can also supplement Akero Therapeutics' financial leverage analysis and stock options assessment as well as various Akero Therapeutics Technical models . Check out the analysis of Akero Therapeutics Correlation against competitors.
To learn how to invest in Akero Stock, please use our How to Invest in Akero Therapeutics guide.

Latest Akero Therapeutics' Short Long Term Debt Total Growth Pattern

Below is the plot of the Short Long Term Debt Total of Akero Therapeutics over the last few years. It is Akero Therapeutics' Short and Long Term Debt Total historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Akero Therapeutics' overall financial position and show how it may be relating to other accounts over time.
Short Long Term Debt Total10 Years Trend
Slightly volatile
   Short Long Term Debt Total   
       Timeline  

Akero Short Long Term Debt Total Regression Statistics

Arithmetic Mean5,717,277
Geometric Mean2,887,110
Coefficient Of Variation154.60
Mean Deviation6,290,843
Median1,810,000
Standard Deviation8,839,096
Sample Variance78.1T
Range25.8M
R-Value0.67
Mean Square Error46.8T
R-Squared0.44
Significance0.01
Slope1,316,582
Total Sum of Squares1093.8T

Akero Short Long Term Debt Total History

202427.3 M
202326 M
202210.9 M
20211.5 M

About Akero Therapeutics Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Akero Therapeutics income statement, its balance sheet, and the statement of cash flows. Akero Therapeutics investors use historical funamental indicators, such as Akero Therapeutics's Short Long Term Debt Total, to determine how well the company is positioned to perform in the future. Although Akero Therapeutics investors may use each financial statement separately, they are all related. The changes in Akero Therapeutics's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Akero Therapeutics's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Akero Therapeutics Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Akero Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Short and Long Term Debt Total26 M27.3 M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Akero Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Akero Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Akero Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Akero Therapeutics Stock:
Check out the analysis of Akero Therapeutics Correlation against competitors.
To learn how to invest in Akero Stock, please use our How to Invest in Akero Therapeutics guide.
You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.

Complementary Tools for Akero Stock analysis

When running Akero Therapeutics' price analysis, check to measure Akero Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Akero Therapeutics is operating at the current time. Most of Akero Therapeutics' value examination focuses on studying past and present price action to predict the probability of Akero Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Akero Therapeutics' price. Additionally, you may evaluate how the addition of Akero Therapeutics to your portfolios can decrease your overall portfolio volatility.
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Stocks Directory
Find actively traded stocks across global markets
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Bonds Directory
Find actively traded corporate debentures issued by US companies
Is Akero Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Akero Therapeutics. If investors know Akero will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Akero Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(3.24)
Return On Assets
(0.20)
Return On Equity
(0.31)
The market value of Akero Therapeutics is measured differently than its book value, which is the value of Akero that is recorded on the company's balance sheet. Investors also form their own opinion of Akero Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Akero Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Akero Therapeutics' market value can be influenced by many factors that don't directly affect Akero Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Akero Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Akero Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Akero Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.